Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enanta Pharmaceuticals, Inc. - Common Stock (NQ:ENTA)

8.715 +0.315 (+3.75%)
Streaming Delayed Price Updated: 9:56 AM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Enanta Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >
FDA Expands AbbVie's Mavyret Label To Include Pediatric Patients With Hepatitis C Infection
FDA approves AbbVie's Mavyret for acute hepatitis C, expanding its use to patients 3 and older with or without cirrhosis after positive trial data. 
Via Benzinga
Thursday's session: gap up and gap down stocks
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
The Analyst Verdict: Enanta Pharma In The Eyes Of 4 Experts
 
Via Benzinga
United Airlines To Rally More Than 20%? Here Are Top Analyst Forecasts For Monday
 
Via Benzinga
Enanta Pharma Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
 
Via Benzinga
4 Analysts Assess Enanta Pharma: What You Need To Know
 
Via Benzinga
Enanta Pharma Earnings Analysis: Q4 Recap
 
Via Benzinga
Enanta Pharma Q4 Earnings Assessment
 
Via Benzinga
CrowdStrike To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Insights into Enanta Pharma Q4 Earnings
 
Via Benzinga
Enanta Pharma: Q4 Earnings Insights
 
Via Benzinga
Earnings Breakdown: Enanta Pharma Q4
 
Via Benzinga
Earnings Scheduled For November 25, 2024
 
Via Benzinga
Enanta Pharma's Earnings Outlook
 
Via Benzinga
A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts
 
Via Benzinga
Recap: Enanta Pharma Q1 Earnings
 
Via Benzinga
Earnings Scheduled For February 7, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. 
Via Benzinga
Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study
Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms while maintaining a favorable safety profile. EDP-323 offers potential as a... 
Via Benzinga
ENTA Stock Earnings: Enanta Pharma Beats EPS, Beats Revenue for Q3 2024
ENTA stock results show that Enanta Pharma beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
ENTA Stock Earnings: Enanta Pharma Misses EPS, Beats Revenue for Q2 2024
ENTA stock results show that Enanta Pharma missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Earnings Preview For Enanta Pharma
 
Via Benzinga
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the... 
Via Benzinga
What 5 Analyst Ratings Have To Say About Enanta Pharma
 
Via Benzinga
Recap: Enanta Pharma Q4 Earnings
 
Via Benzinga
Earnings Scheduled For November 20, 2023
Companies Reporting Before The Bell • Greenland Technologies (NASDAQ:GTEC) is projected to report quarterly earnings at $0.05 per share on revenue of $24.26 million. 
Via Benzinga
Enanta Pharma Earnings Preview
 
Via Benzinga
Analyst Expectations for Enanta Pharma's Future
 
Via Benzinga
The Latest Analyst Ratings for Enanta Pharma
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.